
House
Tom Price
—
Transactions
283
Total transactions associated with this filer
Disclosed purchases
162
$947.2K – $4.0M
Average modeled return
+247.0%
83 of 162 purchases modeled
Average vs. S&P 500
-89.8%
Comparable modeled intervals
MODELED PERFORMANCE
Disclosed purchases vs. S&P 500
12 most recent modeled purchases. The summary and table include all modeled purchases.
MARKET ANALYSIS
Modeled purchase performance · Since purchase
83 of 162 disclosed purchases have modeled returns for this period. 79 purchases have missing or excluded market data; no returns are invented for them.
| Ticker↑↓ | Asset↑↓ | Entry↑↓ | Latest↑↓ | Modeled return↑↓ | S&P 500↑↓ | Relative↑↓ |
|---|---|---|---|---|---|---|
| PJP | Powershares Dynamic Pharmaceutical | Jan 8, 2015 | Nov 6, 2026 | +114.6% | +333.4% | -218.8% |
| DAL | DELTA AIR LINES, INC. | Mar 17, 2016 | Nov 6, 2026 | +104.4% | +327.3% | -222.9% |
| PJP | Powershares Dynamic Pharm | Oct 21, 2014 | Nov 6, 2026 | +135.6% | +362.4% | -226.8% |
| VNQ | F IlINg s TaTus : New Vanguard REIT ETF | Jul 30, 2015 | Nov 6, 2026 | +91.4% | +319.4% | -228.0% |
| VNQ | F IlINg s TaTus : New Vanguard REIT ETF | Jul 30, 2015 | Nov 6, 2026 | +91.4% | +319.4% | -228.0% |
| VNQ | F IlINg s TaTus : New Vanguard REIT ETF | Jul 30, 2015 | Nov 6, 2026 | +91.4% | +319.4% | -228.0% |
| DBB | Powershares DB Base Metals Funds | May 13, 2015 | Nov 6, 2026 | +81.3% | +323.0% | -241.7% |
| SJNK | Spdr Barclays Short Term High Yield Bond | Dec 10, 2015 | Nov 6, 2026 | +78.8% | +327.2% | -248.4% |
| PFE | PFIZER INC | Mar 17, 2016 | Nov 6, 2026 | +69.2% | +327.3% | -258.1% |
| AMG | AFFILIATED MANAGERS GROUP, INC. | Oct 21, 2014 | Nov 6, 2026 | +95.9% | +362.4% | -266.5% |
| CCI | CROWN CASTLE INC. | Mar 17, 2016 | Nov 6, 2026 | +60.5% | +327.3% | -266.8% |
| VZ | VERIZON COMMUNICATIONS INC | Mar 31, 2016 | Nov 6, 2026 | +50.0% | +323.2% | -273.3% |
| BMY | BRISTOL MYERS SQUIBB CO | Mar 17, 2016 | Nov 6, 2026 | +46.9% | +327.3% | -280.4% |
| BA | BOEING CO | Mar 17, 2016 | Nov 6, 2026 | +46.6% | +327.3% | -280.7% |
| CCI | CROWN CASTLE INC. | Oct 21, 2014 | Nov 6, 2026 | +73.7% | +362.4% | -288.7% |
| JAZZ | Jazz Pharmaceuticals plc | Jan 9, 2015 | Nov 6, 2026 | +45.1% | +336.9% | -291.8% |
| LEA | LEAR CORP | Jan 23, 2015 | Nov 6, 2026 | +37.2% | +335.4% | -298.2% |
| CTSH | COGNIZANT TECHNOLOGY SOLUTIONS CORP | Mar 17, 2016 | Nov 6, 2026 | +26.6% | +327.3% | -300.7% |
| LYB | LyondellBasell Industries N.V. | Mar 17, 2016 | Nov 6, 2026 | +23.5% | +327.3% | -303.8% |
| VC | VISTEON CORP | Jan 29, 2015 | Nov 6, 2026 | +35.6% | +341.8% | -306.2% |
| BA | BOEING CO | Jan 29, 2015 | Nov 6, 2026 | +34.2% | +341.8% | -307.6% |
| KMI | KINDER MORGAN, INC. | Jan 9, 2015 | Nov 6, 2026 | +28.8% | +336.9% | -308.1% |
| DAN | DANA Inc | Oct 21, 2014 | Nov 6, 2026 | +52.5% | +362.4% | -309.9% |
| ZBH | ZIMMER BIOMET HOLDINGS, INC. | Mar 17, 2016 | Nov 6, 2026 | +14.8% | +327.3% | -312.5% |
| CVS | CVS HEALTH Corp | Mar 17, 2016 | Nov 6, 2026 | +14.7% | +327.3% | -312.6% |
DISCLOSED ACTIVITY
Recent transaction history
Showing up to 25 records per page · Page 12 of 12 · 283 total transactions
| Ticker↑↓ | Asset↑↓ | Date↑↓ | Type↑↓ | Disclosed amount↑↓ | Source |
|---|---|---|---|---|---|
| A | AGILENT TECHNOLOGIES, INC. | Mar 17, 2016 | sale | $1.0K – $15.0K | Filing ↗ |
| A | AGILENT TECHNOLOGIES, INC. | Jan 8, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
| AMG | AFFILIATED MANAGERS GROUP, INC. | Oct 21, 2014 | purchase | $1.0K – $15.0K | Filing ↗ |
| AET | Aetna Inc. | Mar 17, 2016 | purchase | $1.0K – $15.0K | Filing ↗ |
| AET | Aetna Inc. | Jan 29, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
| ACE | ACE Limited (NYSE) | Jan 29, 2015 | sale | $1.0K – $15.0K | Filing ↗ |
| ABT | ABBOTT LABORATORIES | Mar 17, 2016 | sale | $1.0K – $15.0K | Filing ↗ |
| ABT | ABBOTT LABORATORIES | Jan 29, 2015 | purchase | $1.0K – $15.0K | Filing ↗ |
ANNUAL REPORTING
Annual financial disclosures
| Year | Document | Assets parsed | Status | Source |
|---|
No annual disclosure is currently associated with this filer.
Modeled market performance is calculated from public disclosure dates and historical market prices. It does not represent verified execution prices, realized investment returns, or investment advice. Read the modeling methodology · Review data sources and coverage · Explore other politicians